KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma

BACKGROUND: The incidence and mortality of uterine corpus endometrial carcinoma (UCEC) are increasing yearly. There is currently no screening test for UCEC, and progress in its treatment is limited. It is important to identify new biomarkers for screening, diagnosing and predicting the outcomes of U...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kang, Li, Jingze, Huang, Xuemiao, Zhao, Weixin, Wang, Kai, Wang, Taiwei, Chen, Junyu, Wang, Zeyu, Yi, Jiang, Zhao, Shuhua, Zhao, Lijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913269/
https://www.ncbi.nlm.nih.gov/pubmed/36776306
http://dx.doi.org/10.3389/fonc.2023.1090779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913269/
https://www.ncbi.nlm.nih.gov/pubmed/36776306
http://dx.doi.org/10.3389/fonc.2023.1090779

Ejemplares similares